Modeling the Mitochondrial Cardiomyopathy of Barth Syndrome with Induced Pluripotent Stem Cell and Heart-on-chip Technologies.

Gang Wang,Megan L McCain,Luhan Yang,Aibin He,Francesco Silvio Pasqualini,Ashutosh Agarwal,Hongyan Yuan,Dawei Jiang,Donghui Zhang,Lior Zangi,Judith Geva,Amy E Roberts,Qing Ma,Jian Ding,Jinghai Chen,Da-Zhi Wang,Kai Li,Jiwu Wang,Ronald J A Wanders,Wim Kulik,Frédéric M Vaz,Michael A Laflamme,Charles E Murry,Kenneth R Chien,Richard I Kelley,George M Church,Kevin Kit Parker,William T Pu

DOI: https://doi.org/10.1038/nm.3545

IF: 82.9

2014-01-01

Nature Medicine

Abstract:Cardiomyocytes generated from induced pluripotent cells hold great promise for understanding and treating heart disease. William Pu and his colleagues apply new technologies for studying such cardiomyocytes from patients with Barth syndrome to explore how the mitochondrial defects characteristic of this syndrome lead to heart dysfunction.